Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. (Q53998437)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. (English)

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

author name string

K Hoffman

1

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

F A Holmes

2

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

G Fraschini

3

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

L Esparza

4

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

D Frye

5

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

M N Raber

6

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

R A Newman

7

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

G N Hortobagyi

8

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

publication date

1 January 1996

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

37

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

3

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

254-258

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

https://scigraph.springernature.com/pub.10.1007/bf00688325

0 references

Dual mechanisms of inhibition of DNA synthesis by triciribine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transport, Phosphorylation, and Toxicity of a Tricyclic Nucleoside in Cultured Novikoff Rat Hepatoma Cells and Other Cell Lines and Release of Its Monophosphate by the Cells 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive criteria for assessing therapy-induced toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of tumor necrosis factor alpha on the activity of lipoprotein lipase in adipose tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of tricyclic nucleoside phosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversed-phase high-performance liquid chromatographic determination of tricyclic nucleoside and tricyclic nucleoside 5'-phosphate in biological specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8529286

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00688325

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

release_szwfdd5dobff3ouxkdif5jof3i

1 reference

https://api.fatcat.wiki/v0/release/szwfdd5dobff3ouxkdif5jof3i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8529286

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53998437&oldid=1838439666"